Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
2.890
 +0.340 (13.33%)
  Oct 31, 2025, 5:10 PM SGT
13.33% (1Y)
| Market Cap | 5.46B | 
| Revenue (ttm) | 972.89M | 
| Net Income (ttm) | 648.69M | 
| Shares Out | n/a | 
| EPS (ttm) | 0.84 | 
| PE Ratio | 8.41 | 
| Forward PE | n/a | 
| Dividend | 0.23 (8.96%) | 
| Ex-Dividend Date | Jun 25, 2025 | 
| Volume | 614,500 | 
| Average Volume | 209,160 | 
| Open | 2.750 | 
| Previous Close | 2.550 | 
| Day's Range | 2.750 - 2.920 | 
| 52-Week Range | 1.990 - 3.130 | 
| Beta | n/a | 
| RSI | 58.23 | 
| Earnings Date | Oct 31, 2025 |